Literature DB >> 9282631

The hypoglycemic effect of chloroquine.

V Goyal1, A Bordia.   

Abstract

Ten persons were studied to observe the effect of intravenous administration of chloroquine on serum glucose level. Ten healthy individuals were given 800 mg of chloroquine in three hours infusion. There was a significant (p = 0.001) fall of 25.86 per cent of initial blood glucose level in test group, while it was only 10.47 per cent in control group. Therefore, it is emphasized that seriously III patients and those who are prore to hypoglycemia should be carefully monitored when giving IV chlorquine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9282631

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

Review 1.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 2.  Drug Interactions of Psychiatric and COVID-19 Medications.

Authors:  Niayesh Mohebbi; Ali Talebi; Marjan Moghadamnia; Zahra Nazari Taloki; Alia Shakiba
Journal:  Basic Clin Neurosci       Date:  2020-04-27

3.  Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.

Authors:  Ciska Verbaanderd; Hannelore Maes; Marco B Schaaf; Vikas P Sukhatme; Pan Pantziarka; Vidula Sukhatme; Patrizia Agostinis; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2017-11-23

Review 4.  COVID-19 and type 1 diabetes: dealing with the difficult duo.

Authors:  Subhankar Chowdhury; Soumik Goswami
Journal:  Int J Diabetes Dev Ctries       Date:  2020-07-14

Review 5.  Bisphosphonates for delivering drugs to bone.

Authors:  Shuting Sun; Jianguo Tao; Parish P Sedghizadeh; Philip Cherian; Adam F Junka; Esmat Sodagar; Lianping Xing; Robert K Boeckman; Venkatesan Srinivasan; Zhenqiang Yao; Brendan F Boyce; Brea Lipe; Jeffrey D Neighbors; R Graham G Russell; Charles E McKenna; Frank H Ebetino
Journal:  Br J Pharmacol       Date:  2021-04-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.